Sequenom Revenue and Competitors
Estimated Revenue & Valuation
- Sequenom's estimated annual revenue is currently $300M per year.
- Sequenom's estimated revenue per employee is $1,764,706
- Sequenom's total funding is $185.3M.
- Sequenom has 170 Employees.
- Sequenom grew their employee count by -4% last year.
Sequenom Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Sequenom?
SEQUENOM is a leading genetics company organized into two distinct business units: SEQUENOM Genetic Systems and SEQUENOM Pharmaceuticals. The two business units combine to capitalize on the Company's high performance DNA analysis platform, SNP assay portfolio, disease gene discovery programs and extensive DNA sample repository. SEQUENOM Genetic Systems is dedicated to the sales and support of the Company's MassARRAY products and the continual expansion of platform applications. SEQUENOM Pharmaceuticals applies the power of human genetics to systematically identify disease-related genes that affect significant portions of the overall population. The pharmaceutical unit focuses on disease gene discovery, target identification, functional validation and ultimately diagnostic and therapeutic product development.keywords:Biotechnology
Number of Employees
Employee Growth %
... 2028: Current and Future Opportunities for Key Players, With Covid-19 Impact Analysis: Sequenom, Inc., Quest Diagnostics, Illumina Inc.
Global Prenatal Genetic Testing Market 2022-2028 (Impact of Covid-19) | Sequenom Laboratories, Illumina, Natera, Ariosa Diagnostics, BGI Health.
... in-depth Summary, Growth Factors, Regional Analysis and Forecasts Outlook 2028: Natera, Illumina, Sequenom, Roche, Quest Diagnostics.
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|